ARCT

HEALTHCARE

Arcturus Therapeutics Holdings Inc

$9.13+0.72 (+8.56%)PRE

Live · NASDAQ · May 8, Close

AI Insight

What's Moving ARCT Today?

No stock-specific AI insight has been generated for ARCT yet. Check back soon — insights are generated from recent news analysis.

52-Week Range

$5.85$24.17

$9.13

Fundamentals

Market Cap$260M

P/E Ratio—

EPS$-2.40

Dividend Yield—

Dividend / Share—

ROE-0.3%

Profit Margin-0.8%

Debt / Equity—

Trading

Volume416K

Avg Volume (10D)—

Shares Outstanding28.4M

ARCT News

20 articles

All 20 articles loaded

Price Data

Open$8.68

Previous Close$8.41

Day High$8.83

Day Low$8.22

52 Week High$24.17

52 Week Low$5.85

52-Week Range

$5.85$24.17

$9.13

Fundamentals

Market Cap$260M

P/E Ratio—

EPS$-2.40

Dividend Yield—

Dividend / Share—

ROE-0.3%

Profit Margin-0.8%

Debt / Equity—

Trading

Volume416K

Avg Volume (10D)—

Shares Outstanding28.4M

About Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics Holdings Inc., an RNA drug company, focuses on the treatment of liver and respiratory diseases. The company is headquartered in San Diego, California.

arcturusrx.com

111 employees

Listed May 22, 2013

HEALTHCAREBIOTECHNOLOGY

Company Details

Security TypeStock

ExchangeNASDAQ

CurrencyUSD

Round Lot—

SICBIOTECHNOLOGY

CIK—

Composite FIGI—

Share Class FIGI—